Neurocrine Bioscience buy Wells Fargo & Company
Start price
13.02.26
/
50%
€105.55
Target price
13.02.27
€147.44
Performance (%)
41.45%
Price
16:03
€149.30
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Neurocrine Bioscience has seen massive gains of 41.45%. This prediction currently runs until 13.02.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -5.095% | -5.095% |
| iShares Core DAX® | -1.087% | 0.196% |
| iShares Nasdaq 100 | -2.463% | -1.792% |
| iShares Nikkei 225® | -5.371% | -5.434% |
| iShares S&P 500 | -0.197% | 1.767% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target lowered by analysts at Wells Fargo & Company from $180.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat